The partnership between Acronis and EQT builds upon a shared growth vision, commitment to accelerating the expansion of its platform, and continued focus on customer service.
Acronis and EQT are pleased to announce that the EQT X fund (“EQT”) will acquire a majority stake in the Company. The founders, management, and existing investors – including funds and accounts managed by CVC, Springcoast and BlackRock Private Equity Partners – will remain as significant minority shareholders. Acronis is valued in the transaction above the last growth funding round which was completed in 2022.
Johannes Reichel, Partner and Co-Head of Technology within EQT’s Private Equity advisory team, said, “Acronis is a strongly positioned cybersecurity and data protection software platform with a clear value proposition to Managed Service Providers. We are very excited to partner with Acronis, the management team and existing investors on its next phase of growth.”
EQT has followed the company’s journey for many years and continues to be impressed by its performance and innovative strength.
Partner, Co-Head of Technology, Private Equity – EQT
Ezequiel Steiner, CEO of Acronis, stated, “We are thrilled to have EQT as a major shareholder to support our strategic expansion and share our vision for growth. We would like to thank our existing investors for their support to date and are pleased that many will remain invested as we move forward. But most of all, I’d like to thank the Acronis team for their work in getting us to this stage.”
Founded in 2003, Acronis is an IT solutions vendor for Managed Service Providers, offering a natively integrated, highly efficient cybersecurity and data protection platform. Through its Managed Service Providers channel, Acronis is well positioned to continue scaling its network rapidly. With 15 offices around the globe and more than 1,700 employees, Acronis’ network spans over 150 countries enabling over 20,000 Service Providers to protect over 750,000 businesses.
The completion of this transaction is pending customary regulatory approvals and is anticipated to take place in Q1-Q2 2025.
